SGTL2 inhibitors and amputations in the US FDA Adverse Event Reporting System

Publication date: Available online 18 July 2017 Source:The Lancet Diabetes & Endocrinology Author(s): Gian Paolo Fadini, Angelo Avogaro

Source: The Lancet Diabetes and Endocrinology - July 19, 2017 Category: Endocrinology Source Type: research